Literature DB >> 25680346

Clinical and allergic sensitization characteristics of allergic rhinitis among the elderly population in Istanbul, Turkey.

Ayse Bilge Ozturk1, Leyla Pur Ozyigit2, Merve Ozata Olmez3.   

Abstract

Prevalence of allergic rhinitis (AR) in elderly population in Turkey is not known. Studies on the prevalence and features of allergy in older adults are needed to identify safe and effective diagnostic/therapeutic methods for elderly AR patients. We aimed to identify the clinical and allergic characteristics of sensitization to aeroallergens among individuals aged ≥60 years with allergic rhinitis admitted to an allergy outpatient clinic in Istanbul. Of 109 patients, 33.9 % were atopic. Sixty-five percent of subjects were sensitized to Dermatophagoides pteronyssinus, 17 % to a grass-pollen mixture, 8 % to Aspergillus fumigatus, and 8 % to Blattella germanica. There was no difference between mono- and polysensitized patients in terms of the duration of rhinitis and symptom severity. No significant difference was observed between the two groups according to age, sex, smoking status, AR onset (<40 or ≥40 years), or duration/severity of disease. There was no significant difference between the two groups in the prevalence of asthma and conjunctivitis, (p = 0.256). Atopic dermatitis/eczema was more prevalent in those with AR (p = 0.046). Clinical characteristics of AR in the elderly could be different from those in non-allergic patients, and the prevalence of allergy may be higher than expected.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25680346     DOI: 10.1007/s00405-015-3552-6

Source DB:  PubMed          Journal:  Eur Arch Otorhinolaryngol        ISSN: 0937-4477            Impact factor:   2.503


  10 in total

Review 1.  Allergic rhinitis and its impact on asthma.

Authors:  J Bousquet; P Van Cauwenberge; N Khaltaev
Journal:  J Allergy Clin Immunol       Date:  2001-11       Impact factor: 10.793

2.  Monosensitization and polysensitization in allergic rhinitis.

Authors:  Giorgio Ciprandi; Ignazio Cirillo
Journal:  Eur J Intern Med       Date:  2011-06-08       Impact factor: 4.487

3.  Prevalence of asthma and allergic diseases in Turkish university students in Ankara.

Authors:  A F Kalyoncu; Y Karakoca; A U Demir; R Alpar; V Shehu; L Cöplü; A A Sahin; Y I Baris
Journal:  Allergol Immunopathol (Madr)       Date:  1996 Jul-Aug       Impact factor: 1.667

4.  Clinical and cytologic characteristics of allergic rhinitis in elderly patients.

Authors:  Maria Teresa Ventura; Matteo Gelardi; Angela D'Amato; Rosalba Buquicchio; Roberto Tummolo; Giovanni Misciagna; Giorgio Walter Canonica; Giovanni Passalacqua
Journal:  Ann Allergy Asthma Immunol       Date:  2012-03       Impact factor: 6.347

5.  Epidemiology of IgE-dependent allergic diseases in elderly patients in Poland.

Authors:  Andrzej Bozek; Jerzy Jarzab
Journal:  Am J Rhinol Allergy       Date:  2013 Sep-Oct       Impact factor: 2.467

6.  The prevalence of allergic rhinitis in adults in Aydin, Turkey.

Authors:  Okay Başak; Sema Başak; Berna Gültekin; Nil Tekin; Aydin Söylemez
Journal:  Rhinology       Date:  2006-12       Impact factor: 3.681

7.  The prevalence of asthma and allergy among university freshmen in Eskisehir, Turkey.

Authors:  N Ozdemir; I Uçgun; S Metintas; M Kolsuz; M Metintas
Journal:  Respir Med       Date:  2000-06       Impact factor: 3.415

8.  Seasonal rhinitis, clinical characteristics and risk factors for asthma.

Authors:  B Bozkurt; G Karakaya; A F Kalyoncu
Journal:  Int Arch Allergy Immunol       Date:  2005-08-11       Impact factor: 2.749

9.  Risk factors for asthma and other allergic diseases in seasonal rhinitis.

Authors:  Serhat Celikel; Sacide Rana Isik; Ahmet Ugur Demir; Gul Karakaya; Ali Fuat Kalyoncu
Journal:  J Asthma       Date:  2008-10       Impact factor: 2.515

10.  Allergic diseases in the elderly.

Authors:  Victoria Cardona; Mar Guilarte; Olga Luengo; Moises Labrador-Horrillo; Anna Sala-Cunill; Teresa Garriga
Journal:  Clin Transl Allergy       Date:  2011-10-17       Impact factor: 5.871

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.